Edition:
United Kingdom

People: CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

9.39USD
22 Aug 2019
Change (% chg)

$-0.06 (-0.63%)
Prev Close
$9.45
Open
$9.47
Day's High
$9.47
Day's Low
$9.39
Volume
865
Avg. Vol
144,438
52-wk High
$24.34
52-wk Low
$8.79

Kavanaugh, W. Michael 

Mr. W. Michael Kavanaugh, M.D. serves as a Chief Scientific Officer and Head - Research and Non-Clinical Development of the company. Dr. Kavanaugh joined us as chief scientific officer and head of research and non-clinical development in January 2015. Prior to joining us, Dr. Kavanaugh was senior vice president and chief scientific officer of Five Prime Therapeutics, Inc. From February 2009 to December 2014, Dr. Kavanaugh held multiple positions in research and development at Five Prime Therapeutics, Inc. and led the growth of its therapeutic pipeline. Prior to that, Dr. Kavanaugh served as vice president of Novartis Vaccines & Diagnostics, Inc. and executive director of Oncology Biologics in the Novartis Institutes of Biomedical Research. He joined Novartis as part of its acquisition of the Chiron Corporation in 2006, where he held positions as vice president and head of antibody and protein therapeutics research. Dr. Kavanaugh received his M.D. from Vanderbilt University and his B.S. in molecular biochemistry and biophysics from Yale University. He completed training in internal medicine, cardiovascular disease and molecular and cellular biology at University of California, San Francisco, and the Cardiovascular Research Institute. Dr. Kavanaugh also currently serves as an attending staff physician at the San Francisco Veterans Administration Medical Center and as an associate clinical professor of Medicine at University of California, San Francisco.

Basic Compensation

Total Annual Compensation, USD 427,357
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,347,250
Fiscal Year Total, USD 1,774,610

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Sean McCarthy

5,482,230

Lloyd Rowland

1,793,490

Nick Galli

--

W. Michael Kavanaugh

1,774,610

Rachel Humphrey

2,290,820

Matthew Young

220,418
As Of  31 Dec 2018